ArticleJournal of imaging2026
Hyperelastic Regularization for Near-Diffeomorphic Transformer-Based Brain MRI Registration.
Article in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hyperelastic Regularization for Near-Diffeomorphic Transformer-Based Brain MRI Registration.Journal of imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Transformer-based deformable brain MRI registration achieves high overlap accuracy, but predicted displacement fields can contain voxels with a non-positive Jacobian determinant-local foldings that violate the diffeomorphism assumption required by tensor-based morphometry and atlas-fusion segmentation workflows. We introduce HypEReg, a non-linear hyperelastic regularizer that acts directly on the Jacobian determinant of the predicted displacement field. HypEReg couples a clamped-rational volume-distortion penalty (detJϕ-1)2/max(detJϕ,ϵ) with an explicit per-voxel anti-folding hinge [max(0,ϵ-detJϕ)]2, integrated as a purely loss-side module into a TransMorph backbone with no inference-graph modifications. On the IXI atlas-to-subject benchmark (115 test subjects), HypEReg-TransMorph maintains grouped Dice (0.7537) while reducing the det(Jϕ)≤0 voxel ratio from 1.502×10-2 (TransMorph) to 1.5×10-5, with identical per-case runtime and parameter count to the unregularized baseline. In strict zero-shot transfer to OASIS Learn2Reg test pairs (no fine-tuning), HypEReg-TransMorph achieves Dice 0.7756 with a det(Jϕ)≤0 ratio of 7.6×10-5, roughly two orders of magnitude below plain TransMorph zero-shot (Dice 0.7691; ratio 9.6×10-3); downstream multi-atlas label fusion further confirms the practical benefit of fold suppression (fused Dice 0.8271 vs. 0.8201 for TransMorph). OASIS-2 longitudinal and ROI analyses support deformation plausibility (lower folding/SDlogJ and stronger ventricular ROI agreement), while clinical-covariate associations remain exploratory rather than biomarker-validating. Determinant-level, non-linear hyperelastic regularization substantially suppresses folding in Transformer dense-flow brain MRI registration while preserving alignment accuracy and adding zero inference cost, providing a practical drop-in regularization strategy that improves the reliability of deformation fields for morphometry-oriented deformable registration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.